Read more

April 12, 2023
1 min read
Save

Top in endocrinology: Diabetes drug shortage; thyroid hormone linked to hyperactivity

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

In the past year, prescribers have had difficulties treating people with type 2 diabetes and obesity due to a global shortage of semaglutide and tirzepatide, but that seems to be resolving, according to manufacturers.

“Medication shortages are not a common thing in the United States,” Rodolfo J. Galindo, MD, an associate professor of medicine in the division of endocrinology at University of Miami Miller School of Medicine, told Healio. “We tend to see these shortages for rare indications, for medications that are rarely used. Even a couple of years ago, we had some issues with some medications that were generic for some rare diseases. You don’t see these [shortages] commonly for diabetes.”

Diabetes Words 2019
In the past year, prescribers have had difficulties treating people with type 2 diabetes and obesity due to a global shortage of semaglutide and tirzepatide, but that seems to be resolving, according to manufacturers. Image: Adobe Stock

It was the top story in endocrinology last week.

The second top story covered a study that found children with ADHD were more likely to exhibit hyperactivity behaviors if they had an elevated serum thyroid-stimulating hormone level.

Read these and more top stories in endocrinology below:

Recent diabetes, obesity drug shortages reveal challenges for prescribers

Recent shortages of the type 2 diabetes therapies semaglutide and tirzepatide, widely reported in the consumer press, appear to be resolving, according to manufacturers and prescribers. Read more.

Higher TSH levels linked to hyperactivity behaviors for children with ADHD

Children with ADHD may be more likely to experience hyperactivity behaviors if they have an elevated serum thyroid-stimulating hormone level, according to data published in Neuropsychiatric Disease and Treatment. Read more.

When health plans are detrimental to diabetes care

Susan Weiner, MS, RDN, CDCES, FADCES, talks with Donna Ryan, RN, RDN, MPH, CDCES, FADCES, about changes to standard practices of health plans that could improve diabetes care and health of people with diabetes. Read more.

Abbott warns FreeStyle Libre users about rare cases of battery swelling, overheating

Abbott has issued a voluntary medical device correction to warn users about the potential for battery swelling, overheating or fire with three of its FreeStyle Libre readers. Read more.

CVD risk highest among adults with obesity and genetically predicted low BMI

Adults with a genetically predicted high BMI may have a lower risk for cardiovascular disease than those whose obesity is linked more to environmental factors, according to a study published in eClinicalMedicine. Read more.